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ABSTRACT 
Members of the genus Trichosporon are emerging opportunistic pathogens of 
humans, causing the invasive fungal disease trichosporonosis in 
immunocompromised patients, and summer-type hypersensitivity pneumonitis 
(SHP) in immunocompetent individuals through inhalation of arthroconidia. 
Trichosporonosis is frequently misdiagnosed as candidiasis or cryptococcosis 
due to a lack of awareness and the inaccuracy of immunodiagnostic tests for 
these yeast pathogens. Delays in identification and differentiation of 
Trichosporon spp. from other yeasts and timely administration of appropriate 
antifungal drug treatments add to the poor prognosis and high mortality rate 
associated with this trichosporonosis. This thesis describes the use of 
hybridoma technology to produce two highly specific murine monoclonal 
antibodies (MAbs), CA7 and TH1, for detection and differentiation of 
Trichosporon from other yeast pathogens. The MAbs react with extracellular 
antigens from T. asahii and T. asteroides, the two most common pathogenic 
agents of trichosporonosis. CA7 and TH1 do not recognise related Trichosporon 
spp., or unrelated pathogenic yeasts and moulds including Candida spp., 
Cryptococcus spp., species of Aspergillus, Fusarium, Scedosporium, and 
etiologic agents of mucormycosis. Immunofluorescence and western blotting 
studies show that MAb CA7, an immunoglobulin G1 (IgG1), binds to a major 
~60kDa glycoprotein antigen produced on the surface of hyphae, while TH1, an 
immunoglobulin M (IgM), binds to an antigen produced on the surface of 
conidia. I show how the MAbs can be used with standard mycological growth 
medium (Sabouraud Dextrose Agar) and an enzyme-linked immunosorbent 
assay (ELISA) to accurately differentiate T. asahii from Candida albicans and 
Cryptococcus neoformans in single and mixed species cultures.  
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INTRODUCTION 
The genus Trichosporon contains approximately 50 species of fungi found in a 
wide variety of habitats including soil and indoor environments [1-3]. A number 
of species colonise the skin, gastrointestinal, respiratory and urinary tracts of 
humans [4-7], and superficial Trichosporon infections of immunocompetent 
individuals (for example white piedra infections of the hair shaft [1, 8]) have 
been described for many years [9]. As well as causing superficial infections, 
repeated inhalation of Trichosporon athroconidia can cause summer-type 
hypersensitivity pneumonitis (SHP) [1, 3], an immunologically induced lung 
disease. It is the most common form of hypersensitivity pneumonitis (HP) in 
Japan [10-12] and the number of reports of this disease are increasing [1]. T. 
asahii is the most frequent cause of SHP due to it being the most common 
species of the genus found in the environment [10, 12]. However, other fungi 
may be responsible and correct diagnosis of the disease following identification 
of the causative species is necessary for appropriate treatment, which can be 
challenging due to the number of different techniques required [11, 12]. 
Certain Trichosporon species have emerged as rare but frequently fatal 
pathogens causing invasive, disseminated, infections in immunocompromised 
individuals [4-8, 13-15]. As with SHP, the prevalence of invasive fungal 
infections has increased over the past decade [1, 2, 7, 9, 13, 16, 17] and 
Trichosporon species are now recognised as agents of disseminated yeast 
fungemia, second only in importance to the genus Candida [4, 13, 16-19]. High 
mortality rates are associated with disseminated trichosporonosis [1, 7, 14], with 
reports in the literature of between 50 and 80% mortality in high-risk patient 
groups [9]. 
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Invasive trichosporonosis is mainly found in patients with haematological 
malignancies [7, 9, 13, 16] and granulocytopenia [14]. Incidences of 
haematological malignancies are increasing [13] and the use of 
immunosuppressive therapies [5], chemotherapy [13], corticosteroids [2, 14] 
and organ transplantation [7, 13], are adding to the ever expanding populations 
of patients at high risk for contracting disseminated fungal infections. A further 
risk factor is the use of intravenous catheters [13, 14, 17], since Trichosporon 
spp. can form biofilms on implanted devices, allowing escape from the host 
immune system and antifungal drugs [9]. Other risk factors include the use of 
broad-spectrum antibiotics [8, 13] and previous gastrointestinal/urinary tract 
colonisation by Trichosporon spp [6, 14]. 
Currently, for a proven diagnosis of invasive trichosporonosis 
demonstration of the fungus in tissue biopsy specimens and in culture is 
required [9, 17], but obtaining biopsy samples from critically ill patients is 
problematic. Methods for identifying Trichosporon to species level, based on 
morphological characteristics in culture and biochemical profiling are time 
consuming, require specialist mycological training, appropriately equipped 
laboratory facilities, and often provide inconsistent results [2, 9, 13, 15].  
Molecular methods are necessary to distinguish Trichosporon spp., but no such 
methods have been standardised for clinical use and no commercially available 
tests currently accommodate the revised taxonomic classification of the genus 
[9, 13].  
Early diagnosis of invasive trichosporonosis is critical for prompt and 
effective treatment [4, 17] but this is difficult for Trichosporon infections [4, 13-
15], especially in resource-limited settings with rudimentary diagnostic 
procedures [8], where Trichosporon asahii may be mistaken for Candida spp in 
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culture [2, 8, 16, 20]. Further complications are infections caused by mixed 
yeast or mould species [21], and cross-reactivity of commercial immunoassays 
with Trichosporon, such as the Cryptococcus antigen test [22], leading to mis-
identification and inappropriate use of drugs [15, 23]. 
To facilitate the early treatment of invasive trichosporonosis, 
development of non-invasive diagnostic procedures that allow accurate 
detection of Trichosporon spp. need to be developed [24]. Hybridoma 
technology allows the generation of highly specific monoclonal antibodies 
(MAbs) [25] that can be used to develop rapid and highly accurate 
immunodiagnostic tests capable of differentiating fungal pathogens to genus-, 
species- or even isolate-level from patient samples such as serum [26-28]. This 
paper describes the use of hybridoma technology to develop two murine 
hybridoma cell lines (CA7 and TH1) producing MAbs specific for Trichosporon 
asahii and the closely related species Trichosporon asteroides. The accuracy of 
the MAbs in differentiating T. asahii from other yeast pathogens in mixed 
cultures is demonstrated using a highly specific ELISA.  
 
METHODOLOGY 
Fungal culture 
Trichosporon asahii is currently the most common cause of invasive 
trichosporonosis [4, 18]. Consequently, a clinical isolate of the fungus 
(Trichosporon asahii var. asahii CBS 8972) was used to prepare immunogen for 
immunisation of mice. The fungus was grown in malt yeast liquid medium (MYB; 
bactopeptone, 0.5% w/v; malt extract (OXOID Ltd. Basingstoke, United 
Kingdom; LP0039) , 1.0% w/v; glucose, 0.4% w/v; yeast extract, 0.4% w/v; 
adjusted to pH7.3 with 1M NaOH) or on malt yeast agar (MYA; MY containing 
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2.0% w/v agar). Sabouraud dextrose agar (SDA; 3.0% w/v SD broth (Oxoid; 
CM0147) containing 2.0% w/v agar) was used in mixed species specificity 
screening. Candida, Rhodotorula, Magnusiomyces, Kluyveromyces, 
Geotrichum, Wickerhamomyces and Pichia species were all grown on Glucose-
Peptone-Yeast extract agar (GPYA; 4.0% w/v glucose, 0.5% w/v bacteriological 
peptone, 0.5% w/v yeast extract, 1.5% w/v agar.). Aspergillus, Penicillium, 
Scedosporium, Paecilomyces, Pythium, Alternaria, Verticillium and 
Pseudallescheria species were all grown on Malt Extract Agar (MEA; 2.0% w/v 
malt extract containing 2.0% w/v agar). Malassezia furfur was grown on 
Leeming-Notman agar (LNA; 1.0% w/v bacteriological peptone, 0.5% w/v 
glucose, 0.01% w/v yeast extract, 0.8% w/v ox bile (SIGMA Chemical 
Company, Poole, United Kingdom; 70168), 0.0001% w/v glycerol, 0.05% w/v 
glycerol m-monostearate, 0.00005% w/v Tween-60 (Sigma; P1629), 1.0% w/v  
liquid, whole fat, cow’s milk (Sainsbury’s), 1.2% agar). All other fungi were 
grown on Potato Dextrose Agar (PDA; 2.4% w/v potato dextrose broth (Sigma; 
P6685) containing 2.0% w/v agar). All media were autoclaved at 121°C for 
15mins before use and cultures grown at 26°C with a 16h photoperiod of 
fluorescent light, with the exception of M. furfur which was grown at 30°C in the 
dark. 
 
Preparation of immunogen 
For preparation of the immunogen, flasks containing 100ml of sterile MYB were 
inoculated with 103 spores of T. asahii per ml of medium. The flasks were 
incubated at 26oC with shaking (125rpm) for 2d, after which the contents were 
centrifuged at 4000rpm for 5mins, the bulk of the supernatant was discarded 
and the pelleted cells re-suspended in the remaining liquid. The surface of 2-d-
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old MYA petri-dish cultures were scraped and combined with the re-suspended 
cells. The combined cell preparations were snap frozen in liquid nitrogen, 
lyophilized for 3d and the dried material stored at -20°C prior to use. Before 
immunisation the immunogen was reconstituted with phosphate buffer saline 
(PBS; 137mM NaCl, 2.7mM KCl, 8mM Na2HPO4, and 1.5mM KH2PO4 [pH 7.2]) 
to make a cell suspension containing 10mg per ml of buffer. 
 
Immunisation regime 
Four female BALB/c white mice were each given four injections of immunogen 
into the peritoneum at two-week intervals. Serum obtained from tail bleeds was 
used to monitor antisera titres of the mice by using a Plate-Trapped-Antigen-
Enzyme-Linked-Immunosorbent-Assay (PTA-ELISA). The mouse exhibiting the 
strongest immune response (highest titre of anti-Trichosporon antibodies) was 
selected for hybridoma production and a single booster injection was given 
three days before fusion.  
 
Production of hybridomas  
The selected mouse was euthanized and the spleen removed aseptically and 
stored in 20% tissue culture medium (20% TCM: RPMI 1640 medium containing 
20% fetal bovine serum). Spleen cells were removed by rupturing the spleen 
and left to stand to let the connective tissue settle. The cell suspension was 
transferred to a centrifuge tube and, along with a centrifuge tube of murine 
myeloma cells (Sp2/0-Ag14) (each containing a total of 107 cells), were 
centrifuged at 250g for 5mins. Supernatants from both tubes were discarded 
and the cells were re-suspended in RPMI serum-free medium, before 
combining the myeloma and spleen cells suspensions together. The combined 
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samples were centrifuged at 250g for 5mins. The supernatant was discarded to 
dry the cells and 0.3ml of polyethylene glycol solution (PEG: 0.2ml PEG mixed 
with 0.4ml RPMI1640 serum-free medium) was added. After 6mins, the cells 
were centrifuged for 1min at 500g. The PEG solution was removed, the cells re-
suspended in 5ml of serum-free RPMI medium and added to 95ml of HAT 
(hypoxanthine, aminopterin, thymidine) selective medium (TCM containing 
sterile HAT). 100µl of the HAT-cell suspension was added to wells of sterile 96-
well culture plates and the cells incubated in a CO2 incubator at 37°C. 
 
Screening of hybridomas 
After 7 to 10d, colonies of hybridoma cells were clearly visible in the wells. 
Supernatants bathing hybridomas were screened for Trichosporon MAbs in 
PTA-ELISA tests, using microtitre plates coated with soluble antigens from T. 
asahii and other related and unrelated fungi of clinical significance (see Table.1. 
for species used). 
 
Preparation of antigen coated microtitre plates  
Hybridoma supernatants were tested by PTA-ELISA using 96 well microtitre 
plates (Nunc Maxisorp) coated with antigens from lyophilised cells or with 
antigens prepared as surface washings (see Table. 1. for species used). 
Lyophilised cells were prepared as described for the preparation of the T. asahii 
immunogen. For surface washings, slant cultures of fungi grown at 26°C were 
washed with 3ml PBS using a pipette tip to gently stroke the slant surface. The 
washings were added to 1.5ml eppendorf tubes and centrifuged at 14000rpm 
for 5mins to precipitate spores and hyphae. The resulting supernatants, 
containing soluble antigens, were diluted 1 in 10 in PBS. 50µl samples were 
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used to coat the wells of 96 well microtitre plates and the content incubated 
overnight at 4°C in sealed plastic bags. Plates were washed three times with 
PBST (PBS containing 0.05% [v/v] Tween-20 (polyoxyethylene-sorbitan 
monolaurate)(Sigma; P7949), once each with PBS and dH2O (5min each 
wash), and then air dried in a laminar flow hood. Plates were stored in sealed 
plastic bags at 4°C prior to use. 
 
Organism Isolate number Source 
Trichosporon asahii var. asahii  8972 CBS 
Trichosporon asahii var. asahii  8973 CBS 
Trichosporon asahii var. asahii  5286 CBS 
Trichosporon asahii var. asahii  7632 CBS 
Trichosporon asahii var. asahii 5599 CBS 
Trichosporon asahii  2479 CBS 
Trichosporon asteroides 6183 CBS 
Trichosporon asteroides  7623 CBS 
Trichosporon asteroides  2481 CBS 
Trichosporon asteroides  7624 CBS 
Trichosporon cutaneum  2466 CBS 
Trichosporon dermatitis  2043 CBS 
Trichosporon inkin  7630 CBS 
Trichosporon inkin  7655 CBS 
Trichosporon loubieri  7065 CBS 
Trichosporon mucoides 7625 CBS 
Trichosporon mycotoxinivorans  9756 CBS 
Trichosporon ovoides  7556 CBS 
Alternaria infectoria  137.9 CBS 
Aspergillus cervinus  537.65 CBS 
Aspergillus fumigatus  AF293 SK 
Aspergillus nidulans  A4 FGSC 
Aspergillus niger 102.4 CBS 
Aspergillus oryzae AO1 CRT 
Aspergillus terreus var. terreus  601.65 CBS 
Botrytis cinerea R2 CRT 
Candida albicans  5314 SB 
Candida dubliniensis var. dubliniensis  8500 CBS 
Candida glabrata  4962 CBS 
Candida krusei  5590 CBS 
Candida parapsilosis var. parapsilosis 8836 CBS 
Candida tropicalis var. tropicalis  1920 CBS 
Table. 1. 
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Cryptococcus neoformans serotype D 5728 CBS 
Cryptococcus neoformans var. neoformans  7779 CBS 
Cryptococcus saitoi  1975 CBS 
Cunninghamella elegans  151.8 CBS 
Filobasidiella bacillispora  10865 CBS 
Filobasidiella neoformans  10490 CBS 
Filobasidiella neoformans  10496 CBS 
Fusarium oxysporum f.sp. lycopersici 167.3 CBS 
Fusarium solani 224.34 CBS 
Geotrichum candidum  115.23 CBS 
Kluyveromyces marxianus  3073 CBS 
Lichtheimia corymbifera  TJAFJ713070 CRT 
Magnusiomyces capitatus 207.83 CBS 
Malassezia furfur 9596 CBS 
Paecilomyces variotii 10.1 10.1 CRT 
Penicillium islandicum 338.48 CBS 
Pichia norvegensis  6564 CBS 
Pseudallescheria boydii 835.96 CBS 
Pythium ultimum var. ultimum 656.68 CBS 
Rhizomucor miehei  360.92 CBS 
Rhizopus stolonifer var. stolonifer 389.95 CBS 
Rhodosporidium toruloides  6016 CBS 
Rhodotorula mucilaginosa var. mucilaginosa  326 CBS 
Scedosporium apiospermum  117407 CBS 
Scedosporium prolificans  467.74 CBS 
Sporidiobolus salmonicolor 6781 CBS 
Verticillium dahliae 178.66 CBS 
Wickerhamomyces anomalus  5759 CBS 
 
 
 
 
Plate-Trapped-Antigen-Enzyme-Linked-Immunosorbent Assay (PTA-ELISA) 
Wells were blocked for 15mins with 100µl of PBS containing 1% Bovine Serum 
Albumin (BSA) and, after one 5min wash with PBS, 50µl of primary antibody 
was added to each well and incubated for 1h. For testing of tail bleeds, the wells 
were incubated with a doubling dilution of serum in PBST. For screening of 
hybridomas, 50µl of hybridoma supernatant was added to the wells and TCM 
Table. 1. continued 
Table. 1. Fungal species used with their respective isolate numbers and source. CBS; 
Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands. SK; S. Krappman, Institute of 
Microbiology and Genetics, Department of Molecular Microbiology and Genetics, Georg-August 
University, Gottingen, Germany. FGSC; Fungal Genetics Stock Centre, University of Missouri, 
Kansas City. CRT; C. R.Thornton, University of Exeter, England. SB; S. Bates, School of 
Biosciences, University of Exeter 
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was used as the negative control. Plates were given three 5min washes with 
PBST before adding 50µl of goat anti-mouse polyvalent (IgG, IgA, IgM) 
peroxidise conjugate (Sigma; A-0412) diluted 1/1000 in PBST, and incubated 
for a further hour. Plates were washed again three times with PBST and then 
once with PBS. 50µl of tetramethyl benzidine (TMB)(Sigma; T2885)(48.54% 
[v/v] Milli-Q water, 48.54% [v/v] 0.2 sodium acetate, 1.89% [v/v] sodium citric, 
0.05% [v/v] H2O2, 0.98% [v/v] TMB (10 mg/ ml)) substrate solution was added to 
the wells for 30mins to visualise any bound antibody, and the reaction stopped 
by adding 50µl of 3M H2SO4 to each well. Absorbance values were measured at 
450nm using an automated plate reader (iMarkTM microplate reader MPM6, 
BIORAD, Hertfordshire, UK). All incubation steps were performed in sealed 
plastic bags at 23°C. 
 
Sub-cloning of positive hybridomas 
Hybridoma cells were dislodged from the well surface by gently flushing with the 
TCM supernatant, and 50µl of the cell suspension added to 5ml warmed TCM in 
a sterile universal tube. This dilution was labelled ‘dilution B’ and from this, 
100µl was added to 10ml of TCM in a universal tube, labelled ‘dilution C’. From 
dilution C, 1ml was added to a tube labelled ‘dilution D’ (containing 4ml of 
TCM), and 500µl added to a tube labelled ‘dilution E’ (containing 4.5ml of TCM). 
Before transferring volumes between dilutions, cell suspensions were mixed 
gently to ensure even cell distribution. Each dilution was plated out into half of a 
96 well culture plate, at 100µl per well. The plates were incubated at 37°C and 
5% CO2 and fed after 5d with fresh TCM.   
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Expansion of cell lines and cryopreservation 
Antibody positive cells lines were expanded in stages, from 96 well plates to 24 
well plates, 6 well plates and then into petri dishes. As with limiting dilutions, 
cells were dislodged from the well surface by washing with their supernatant 
before removal of cell suspension from culture vessels. Prior to 
cryopreservation, cells lines were sub-cultured into to petri dishes approximately 
24h prior to freezing to produce cultures of dividing cells. The contents of two 
plates each containing 25ml of cell suspension were added to sterile 50ml 
falcon tubes and the cells pelleted by centrifugation at 2000rpm for 5mins. The 
supernatant was discarded and the cells re-suspended in 600µl of freezing 
medium (fetal bovine serum and dimethyl sulfoxide 92:8 [v/v]). Cells were slowly 
frozen in cryovials at -80°C and stored long-term in liquid nitrogen. 
 
Antibody isotyping 
Immunoglobulin class was determined by using PTA-ELISA. Wells containing 
immobilised T. asahii antigen, were incubated with 50µl hybridoma supernatant 
for 1h. Following three 5min washes with PBST, the wells were incubated for 
30mins with goat anti-mouse IgG1, IgG2a, IgG2b, IgG3, IgM or IgA – specific 
goat antiserum (Sigma; ISO-2), each diluted 1 in 3000 in PBST. Plates were 
washed again with PBST and incubated for a further 30min with rabbit anti-goat 
peroxidise conjugate (Sigma; A-5420) diluted 1 in 1000 in PBST. Plates were 
washed three times with PBST and once with PBS, before bound antibody was 
visualised with TMB substrate as described previously. 
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Antigen characterisation by heat treatment 
6ml of immunogen was added to three 15ml falcon tubes and placed in a boiling 
water bath. At 10min intervals, 1ml was removed from each falcon tube and the 
samples centrifuged before analysing the supernatant by PTA-ELISA. 
 
Antigen characterisation by periodate oxidation 
Wells containing immobilised immunogen were incubated with 50µl of sodium 
meta-periodate solution (20mM NaIO4 in 50mM sodium acetate buffer [pH4.5]) 
at 4°C in sealed plastic bags. Plates were given four, 3min PBS washes before 
processing by PTA-ELISA as described previously. 
 
Antigen characterisation by protease digestion 
Wells containing immobilised immunogen were incubated with 50µl of pronase 
(protease XIV (Sigma; P2143); 9mg/ml in PBS) or trypsin (T7168)(1mg/ml in 
Milli-Q H2O) solution for 4h at 37°C or 4°C. Plates were given four, 3min rinses 
with PBS. Treated wells were assayed by PTA-ELISA as described previously. 
 
PAGE and Western blotting 
SDS-PAGE was carried out using 4-20% (w/v) gradient polyacrylamide gels 
under denaturing conditions.  Surface washings of T. asahii var. asahii CBS 
8972, T. asteroides CBS 6183 and T. inkin CBS 7630 cultures on PDA slants 
were taken every 24h after inoculation, using 3ml of sterile Milli-Q water in place 
of PBS. The supernatant was added to eppendorfs and frozen for storage until 
use. At the time of use, samples were thawed, vortexed and centrifuged for 
5mins at 14000rpm to precipitate cells and hyphae. The supernatants, 
containing soluble antigens were denatured by mixing with Laemmli buffer [29] 
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and heating at 95°C for 10mins in the presence of β-mercaptoethanol, prior to 
gel loading. Proteins were separated for 1.25h at 23°C (165V). Pre-stained, 
broad-range markers (Bio-Rad Laboratories Limited, Hemel Hempstead, UK) 
were used for molecular mass determination. 
For western blotting, separated proteins were transferred electrophoretically on 
to a polyvinylidene difluoride (PVDF) membrane for 2h at 75V. Membranes 
were washed three times with PBS and then blocked for 16h at 4°C, with PBS 
containing 1% (w/v) bovine serum albumin (BSA). Blocked membranes were 
incubated with MAb supernatant, (diluted 1 in 2 with PBS containing 0.5% [w/v] 
BSA (PBSA)), for 2h at 23°C. After washing three times with PBS, membranes 
were incubated for 1h with goat anti-mouse alkaline phosphatase conjugate, 
diluted 1 in 15,000 in PBSA (either IgM µ-chain specific, Sigma; A9688 or IgG 
whole molecule, Sigma; A3562, depending on determined isotype). Membranes 
were washed three times with PBS, once with PBST and bound antibody 
visualised by incubation in substrate solution [26]. Reactions were stopped by 
immersing membranes in dH2O and membranes were then air dried between 
sheets of Whatman filter paper.  
 
Immunofluorescence 
Sterilised slides were coated with a yeast cell suspension containing 1% w/v 
glucose and incubated at 26°C for 16h. After air drying, the slides were fixed in 
fixative solution (ethanol/chloroform/3% paraformaldehyde solution 6:3:1 by 
volume) for 3mins, followed by immersion in 95% methanol for 4mins and 
washed once in dH2O before air drying. Hybridoma supernatant was added to 
the slides and incubated for 1h, followed by three, 5min PBS washes. Slides 
were then incubated with goat anti-mouse polyvalent fluorescein isothiocyanate 
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conjugate (diluted 1 in 40 in PBS)(Sigma; F1010) for 30mins. Slides were given 
3x5min washes with PBS and mounted in PBS-glycerol mounting medium 
before overlaying with coverslips. Slides were examined using a fluorescence 
microscope (Olympus IX81), under UV. All incubation steps were performed at 
23°C in a humid environment, to prevent evaporation. Slides were stored in the 
dark, to prevent bleaching, at 4°C. 
 
Mixed yeast culture screen 
A yeast inoculating loop was used to inoculate SDA plates with the surface 
washing suspension from slant cultures and grown at 26°C. After 24h, surface 
washings of the plates were taken using 10ml PBS and samples were 
processed by PTA-ELISA. 
 
RESULTS 
Production of hybridoma cell lines and isotyping of MAbs 
Two fusions were performed and 1284 hybridoma cell lines were screened for 
MAb production by PTA-ELISA. Two of the MAbs (CA7 and TH1) were selected 
for further testing on the basis of their high absorbance values (A450 0.400 and 
A450 1.122 respectively). The cell line CA7 was sub-cloned twice and TH1 sub-
cloned three times. Isotyping of the MAbs showed that CA7 belongs to 
immunoglobin class G1 (IgG1) and TH1 to immunoglobin class M (IgM). 
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MAb specificity tests 
In secondary specificity screening tests, CA7 and TH1 reacted strongly in PTA-
ELISA against surface antigens from T. asahii and T. asteroides. Even though 
CA7 failed to recognise T. asahii var. asahii CBS 5286, TH1 gave a positive 
absorbance value (Abs450 >0.100) for this strain. Together the MAbs gave a 
combined positive reaction with all strains tested of the two species (FIG. 1.).  
The antibodies did not react with surface antigens from other 
Trichosporon species or a broad range of other clinically important yeasts and 
moulds such as Candida, Cryptococcus and Aspergillus species [30-32]. The 
MAbs were also tested against other emerging invasive pathogens such as 
Rhodotorula [19, 33], and the other causative agent of white piedra (folliculitis) 
Malassezia furfur [34]. Neither MAb reacted with surface antigens from these 
species. 
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FIG. 1. 
FIG. 1. Absorbance values from secondary specificity screening of MAbs against surface washing antigens. (A) 
CA7 (B) TH1 by PTA-ELISA, against surface washing antigens. Each bar represents the average of 8 technical 
replicates with the average TCM values subtracted. Threshold for positive value = +0.100 (shown by line on 
graph) and error bars shown = ±standard error. 
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Characterisation of antigen 
The T. asahii var. asahii CBS 8972 freeze dried antigen was subjected to 
different treatments including heat treatment (FIG. 2G) or periodate, pronase 
and trypsin treatments (FIGS. 2A-F).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Periodate (+) Buffer (-) Time (h) 
FIG. 2. 
FIG. 2. Absorbance of MAb binding against treated antigen. (A) TH1 and (B) CA7 against 
periodate treated antigen =       , treatment time shown in hours, each bar represents the 
average of 8 technical replicates; (C) TH1 and (E) CA7 against trypsin treated antigen =      , (D) 
TH1 and (F) CA7 against pronase treated antigen =       , each bar represents the average of 12 
technical replicates; respective buffer solutions =      ; (G) 100°C, each point shown represents 
the average of 3 biological replicates (each with 4 technical replicates) with average TCM 
values subtracted.  (A) TH1, one-way ANOVA (F(11,84) = 17.12, p= <0.001); (B) CA7, one-way 
ANOVA (F(11,84) = 14.02, p= <0.001); (C) TH1, one-way ANOVA (F(3,44) = 0.62, P=0.607); 
(D) TH1, one-way ANOVA (F(3,44) = 19.21, p<0.001);  (E) CA7, one-way ANOVA (F (3,44) = 
23.97, p<0.001); (F) CA7, one-way ANOVA (F (3,44) = 57.16, p<0.001); Tukey-kramer: results 
that do not share a letter are significantly different; (G) TH1, one-way ANOVA (F(6,77) = 163.54, 
p<0.000); CA7, one-way ANOVA (F(6,77) = 4.39, p=0.001); Tukey-kramer: asterisks show 
significant decrease compared to time point zero. Error bars shown = ±standard error 
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FIG. 2. Continued. 
Trypsin (+) Buffer (-) Pronase (+) Buffer (-) 
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Following 40mins, or longer, of boiling treatment of the antigen, CA7 binding 
ability to the antigen was significantly reduced compared to no heat treatment 
(p<0.001) (FIG. 2G). CA7 binding to the antigen was also statistically 
significantly reduced (p<0.001) following periodate treatment for 4 and 23h 
(FIG. 2B), pronase treatment at 37°C and 4 °C (FIG. 2F) and trypsin treatment 
at 37°C (FIG. 2E) compared to treatment with the respective buffer solutions. 
TH1 binding to the antigen was also significantly reduced following 
boiling treatment of the antigen after 10mins, compared to no boiling treatment 
(FIG. 2G), periodate treatment for 23h (FIG. 2A) and pronase treatment at 37°C 
(FIG. 2D), when compared to the controls (p<0.001). Trypsin treatment of the 
antigen did not significantly reduce TH1 binding (FIG. 2C). 
 
PAGE and Western blotting 
Surface washings of fungal slant cultures were taken every 24h and the 
samples used for SDS-PAGE and western blotting studies.  
CA7 reacted to immuno-reactive glycoprotein antigen(s) with molecular 
weights in the region 48-74KDa (FIG. 3A). TH1 did not bind to an immuno-
reactive antigen in western blotting studies. 
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Treatment 
FIG. 3. (A) Analysis of antigen by PAGE and Western Blotting. Lane 1, Western immunoblot with 
MAb CA7 after separation of antigen from T. asteroides (72h of growth), by sodium dodecyl 
sulphate PAGE under reducing conditions; the well was loaded with 40µl of sample; Lanes 2 and 
3, molecular mass marker; Lane 4, Western immunoblot with MAb CA7 after separation of 
antigen from T. asahii (96h of growth), by sodium dodecyl sulphate PAGE under reducing 
conditions; the well was loaded with 40µl of sample; Lane 5, Western immunoblot with MAb CA7 
after separation of antigen from T. inkin (96h of growth), by sodium dodecyl sulphate PAGE 
under reducing conditions; the well was loaded with 40µl of sample. (B-G) Photomicrographs of 
T. asahii var. asahii CBS 8972 immunostained with MAb: (B, C) CA7, (D, E) TH1, (F, G) TCM as 
negative control and anti-mouse polyvalent Ig fluorescein isothiocyanate. (B) conidium with 
hyphae examined under a brightfield microscope. (C) Same field of view in panel B but examined 
under fluorescence, note the staining of hyphae and not conidia. (D) conidium with hyphae and 
ungerminated conidia examined under a brightfield microscope. (E) Same field of view in panel D 
but examined under fluorescence, note staining of conidia not hyphae. (E) conidium with hyphae 
examined under a brightfield microscope. (F) Same field of view in panel E but examined under 
fluorescence, no staining seen in negative control. Bar, 8µm. 
 
FIG. 3. 
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Immunofluorescence  
T. asahii var. asahii CBS 8972 cells were cultured for 16h on slides in sterile 1% 
(w/v) glucose solution. The slides were processed for immunofluorescence and 
viewed at x100 under bright field and immunofluorescence microscopy. 
Immunofluorescence studies showed that CA7 binding was specific to 
the surface of hyphae (FIG. 3C), whereas TH1 binding was specific to the 
surface of conidia (FIG. 3E). 
 
Mixed yeast culture screen 
Yeasts were cultured on SDA plates for 24h (FIG. 4A) before surface washings 
were prepared and tested by PTA-ELISA using both MAbs (FIG. 4B&C). 
Monoclonal antibodies CA7 (FIG. 4B) and TH1 (FIG. 4C) were highly accurate 
in detecting T. asahii var. asahii CBS 8972 both when grown individually, and 
when grown on plates containing mixed populations of C. albicans SC 5314 and 
C. neoformans var. neoformans CBS 7779. The MAbs did not cross react with 
C. albicans or C. neoformans, when grown either as single species or as mixed 
populations.  
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FIG.4. 
FIG. 4 (A) SDA plates inoculated with species in sections; Ta indicates T. asahii var. asahii CBS 
8972, Ca indicates C. albicans SC 5314 and Cn indicates C. neoformans var. neoformans CBS 
7779. (B) CA7 and (C) TH1 absorbance values after surface washings of SDA plates processed 
by ELISA, each bar shown represents the average of 3 biological replicates (each with 6 
technical replicates) with average TCM values subtracted. CA7, one-way ANOVA (F (6,119) = 
504.90, p<0.001). TH1, one-way ANOVA (F (6,119) = 1078.57, p<0.001). Tukey-kramer: results 
that do not share a letter are significantly different and error bars shown =± standard error. 
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DISCUSSION 
This thesis describes the production of two murine MAbs, CA7 and TH1, raised 
against surface antigens from Trichosporon asahii var. asahii CBS 8972. 
 
Specificity screening 
Specificity screening showed that both MAbs reacted only with antigens from 
the species Trichosporon asahii and Trichosporon asteroides. CA7 gave a 
positive absorbance value (higher than the detection threshold of Abs450 0.100 
following correction for TCM negative controls) by PTA-ELISA for all T. asahii 
and T. asteroides strains tested, with the exception of T. asahii var. asahii CBS 
5286. TH1 reacted positively for 5 of the 10 strains tested, including T. asahii 
var. asahii CBS 5286. When combined in ELISA tests, the MAbs were able to 
detect all of the isolates of T. asahii and T. asteroides tested.  
Trichosporon asahii is the principal etiologic agent of trichosporonosis in 
humans [4]. While T. asteroides was originally described as a pathogenic agent 
of superficial infections [35], it’s prevalence as an agent of disseminated 
infection is increasing, since the first recorded case of T. asteroides 
trichosporonosis in 2002 [20]. Currently, the species is reported to be second 
only to T. asahii as the cause of trichosporonosis in immunocompromised 
patients [13]. Consequently, MAbs CA7 and TH1 represent useful diagnostic 
reagents for the immunodetection of the most important agents of this disease.  
Recognition of these two species, but lack of recognition of the other 
Trichosporon species tested, may be explained by their close phylogenetic 
relatedness. Phylogenetic studies of the Trichosporon genus have shown 
Trichosporon asahii and Trichosporon asteroides belong to a distinct clade, 
clade ovoides [1, 13], and are phylogenetically very similar [36]. Comparisons of 
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their ITS (internal transcribed spacer) regions show 98.7% similarity and for the 
intergenic spacer 1 (IGS1), 75.1% similarity [13]. When the mitochondrial 
cytochrome b genes of the species are compared, DNA sequences are 
synonymous and differ by only 4.0%, meaning that the two species contain 
proteins with identical amino acid sequences [35].  
Misdiagnosing invasive trichosporonosis as candidiasis is an important 
limitation to timely treatment of patients with appropriate antifungal drugs [8, 
20]. Further confusion to species identification exists with the cryptococcal latex 
agglutination test, used for the diagnosis of Cryptococcus infections, whereby 
the cryptococcus test has been documented to cross react with Trichosporon 
[17, 22]. Trichosporon and Cryptococcus both secrete glucuronoxylomannans 
(GXM) and common domains are shared between the polysaccharides of the 
two species, forming antigens detected by the test [18]. Cryptococcal meningitis 
is described as an AIDS defining illness [33, 37] and the most common cause of 
adult meningitis [38, 39]. Although Cryptococcus neoformans is the species 
most frequently detected in meningitis patients, other species are isolated, 
including emergent human pathogens such as Trichosporon and Rhodotorula 
[33].  
The activity of fungicides varies against different pathogenic fungi [39-42] 
highlighting the importance of being able to distinguish the causal agent of 
invasive infections (for example Trichosporon, Candida and Cryptococcus) so 
that the most appropriate therapeutic agent can be selected. It was therefore 
important in this study to ensure that both CA7 and TH1 did not cross react with 
surface antigens from Cryptococcus and Candida species, which was confirmed 
by secondary specificity screening tests. 
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The MAbs were screened against other clinically important species and 
emerging human pathogens that may be found in the same environment, all of 
which were not recognised by either MAb, demonstrating the high specificity of 
CA7 and TH1.  
 
Antigen characterisation 
Antigen characterisation indicated that CA7 and TH1 bound to antigen(s) 
containing both carbohydrate and protein components. 
 Treatment of the antigens with periodate prior to processing by PTA-
ELISA significantly reduced both CA7 and TH1 binding after 4 and 23h 
respectively, indicating the presence of vicinal hydroxyl groups on carbohydrate 
moieties [27].  
Reduction in the binding of both MAbs to the antigen(s) after treatment 
with pronase demonstrated the presence of protein components in both of the 
antigen(s) recognised. More specifically, the reduction in CA7 binding following 
trypsin treatment at 37°C indicated that the antigen bound by CA7 contains 
positively charged lysine and arginine side chains [24]. Reduced binding ability 
of a MAb to an antigen following heat treatment indicates the presence of heat-
labile protein components [43]. Antigen recognition by CA7 and TH1 was 
significantly reduced after 40 and 10mins of boiling respectively, further 
indicating the presence of protein components in the antigen(s).  
Western Blotting studies showed that CA7 bound to a major glycoprotein 
antigen with a molecular weight of approximately 60KDa. The carbohydrate 
components of the glycoprotein may be providing heat stability to the antigen(s) 
structure and explain why, despite being significantly reduced, the MAb 
produced an ELISA absorbance value above the positive threshold value, even 
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after 1h of boiling the antigen. The antigen recognised by TH1 was shown to be 
heat labile, significantly reducing TH1 binding after only 10 minutes of boiling of 
the antigen. Heating the antigen at 95°C during the denaturing step for SDS-
PAGE may have caused the same reduction in binding ability and explain why 
TH1 did not bind to an immuno-reactive antigen during western blotting studies. 
Immunofluorescence studies showed that the MAbs recognise antigens 
present on different morphological structures of Trichosporon asahii. CA7 
binding was specific to antigen(s) present on the surface of hyphae, whereas 
TH1 binding was specific to the surface of conidia. Importantly, in combination, 
the MAbs are able to recognise both yeast and filamentous forms, as these 
different growth stages of the pathogen are implicated in tissue invasion of 
disseminated infections [14]. The different morphologies have also been seen in 
the formation of plaques [44] which, as previously mentioned, are an important 
risk factor associated with invasive trichosporonosis and, when present on 
devices such as catheters, allows the fungus to evade treatment with fungicides 
[9]. 
 
Mixed yeast culture screen 
The increasing problem of patients with fungemia caused by mixed species 
infections and diagnosis of causative agents from mixed yeast cultures gave 
motivation to test the MAbs in mixed culture conditions. Trichosporon asahii var. 
asahii CBS 8972, Candida albicans SC 5314 and Cryptococcus neoformans 
var. neoformans CBS 7779 were cultured on the standard mycological growth 
medium SDA. Some mycological laboratories favour the use of selective media 
such as CHROMagar Candida, designed to aid identification and differentiation 
of yeasts by the presence of chomogenic substrates in the media that react with 
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species specific enzymes producing coloured colonies [45]. However limitations 
of CHROMagar media exist, for example the media struggles to detect mixed 
yeast cultures if one species is significantly more prevalent than others showing 
only the colour of the dominant phenotype [23] and, although a useful tool, the 
medium is recommended for use in combination with other culture media for 
complete isolation of species [21]. Consequently, it remains a presumptive test 
requiring further mycological analysis for definite species identification [23, 45, 
46]. 
To avoid species competition, the yeasts were plated in defined sectors 
in SDA plate cultures. The results show that both MAbs correctly recognised the 
presence of T. asahii when grown individually and in combination with C. 
albicans and C. neoformans.  CA7 absorbance values were statistically 
significantly reduced when grown in combination with the other yeasts, however 
these values were still well above the threshold positive value for detection. 
Identification of T. asahii was completed 3 days after inoculation of the SDA 
plates, following 24 h of growth and 2 days of processing the samples by PTA-
ELISA. This provided a short detection time and definitive differentiation of T. 
asahii from both C. albicans and C. neoformans. 
Building on this study, it will be important to test the MAbs against 
samples of yeasts grown with cells mixed together, rather than separated on the 
plate, and at varying ratios to one another. This would more accurately replicate 
cultures that would be obtained from patient samples suffering from co-
infections. 
It is not known at present if antigenic markers from T. asahii and T. 
asteroides could be detected during human fungemia by using serum samples 
or for SHP detection using bronchoalveolar lavage fluid (BALf). If they are 
  
 
30 
 
present in such samples then there is potential for development of the MAbs 
into point-of-care tests that can be used directly with human samples, rather 
than after culture of the pathogen. For example, lateral flow devices (LFD’s), 
which have already been shown to have application in the detection of 
disseminated invasive fungemia, for instance, using serum and BALf samples 
for the detection of invasive aspergillosis [24, 47]. Use of BALf has also been 
demonstrated in the diagnosis of SHP [48] through the detection of fungal DNA 
[12], and might also be used for the LFD detection of T. asahii diagnostic 
antigens in SHP patients. A major advantage of using LFD’s as immunoassays 
is the speed at which a result can be obtained [47, 49, 50], furthermore the 
portable assays can be performed at the site of patient care, further reducing 
sample analysis time. In addition, because of the simplicity of the assay format, 
they require less training in comparison to many laboratory based assays and 
using samples such as serum removes the need for invasive sampling 
procedures [24, 49, 51]. 
It is important to note that while the combination of the MAbs here detect 
the two most common causes of invasive trichosporonosis (T. asahii and T. 
asteroides) and the most common agent of SHP (T. asahii), the other species 
implicated in superficial and invasive infections (a continually expanding list 
including T. inkin and T. cutaneum [4, 52]) and SHP (currently the only other 
member of the genus noted as a causative agent is T. mucoides [11, 12]) would 
require differentiation with PCR sequencing of DNA sequences that have 
sufficient species differences such as the IGS1 region. 
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CONCLUSION 
Hybridoma technology was used to produce two murine MAbs which react with 
antigens from T. asahii and T. asteroides, the principal agents of superficial and 
invasive infections in humans and of SHP. The MAbs, CA7 and TH1, bind to 
antigens present on the surface of hyphae and conidia respectively and can 
distinguish T. asahii from other yeasts when grown in mixed species cultures. 
There is potential for further development of the MAbs into diagnostic 
immunoassays of trichosporonosis and SHP. 
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